# A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety of MEDI-559 in Healthy 1 to <24 Month-Old Children

> **NCT00767416** · PHASE1,PHASE2 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 116 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** MEDI-559
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00767416
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2016-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00767416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00767416, "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety of MEDI-559 in Healthy 1 to <24 Month-Old Children". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00767416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*